Deutsch
A A A
DE
Bereichsnavigation

Previous
Disclosure of voting rights | 11/29/2013

RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


RHÖN-KLINIKUM AG

29.11.2013 11:35

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.




Notification according to section 26 para. 1 WpHG

Prof. Dr. Ludwig Georg Braun, Martin Lüdicke, B. Braun Holding GmbH & Co.
KG, BraHo Verwaltungsgesellschaft mbH, Ludwig G. Braun GmbH & Co. KG and B.
Braun Melsungen Aktiengesellschaft have informed RHÖN-KLINIKUM AG on
November 27, 2013 and Ilona Braun has informed RHÖN-KLINIKUM AG on November
28, 2013 (the aforementioned persons collectively the 'Notifying Persons'),
that their voting interest in RHÖN-KLINIKUM AG has exceeded the threshold
of 15% on November 27, 2013.

With respect to the objectives pursued with the acquisition of the voting
rights, the Notifying Persons have informed us on November 28, 2013,
pursuant to Section 27a(1) of the German Securities Trading Act
(Wertpapierhandelsgesetz - WpHG) as follows:

1. The investment is used to implement strategic objectives.

2. Within the next twelve months, the Notifying Persons intend - within
their plan to sustainably secure their minority shareholding in
RHÖN-KLINKUM AG - to obtain further voting rights by acquisition or any
other way.

3. The Notifying Persons intend to obtain a representation on the
supervisory board of RHÖN-KLINIKUM AG relative to the significance of
their shareholding in RHÖN-KLINIKUM AG. Beyond that, the Notifying
Persons do not intend to influence the composition of the
administration, management or supervisory board of RHÖN-KLINIKUM AG.

4. The Notifying Persons do not intend to change the capital structure of
RHÖN-KLINIKUM AG, especially with regards to the ratio of
internal/outside financing and the dividend policy.

5. The Notifying Persons have used partly own funds and predominantly
external funds in order to finance the purchase of the voting rights.

Bad Neustadt a.d. Saale, 29 November 2013

The Board of Management

________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



29.11.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de




Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Internet: www.rhoen-klinikum-ag.com

End of Announcement DGAP News-Service